Al-Hajj et al. [37] first demonstrated thepresence of a cell subpopulation displaying stem cell properties, characterizedby the cell surface marker profile CD44+/CD24low/lin−,in solid tissues and in pleural effusions of patients with advanced-stagemetastatic breast cancer. Here, CD44 is linked to breast carcinoma.